These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32113686)

  • 1. Role of plasminogen activator inhibitor-1 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells.
    Yamagami Y; Kawami M; Ojima T; Futatsugi S; Yumoto R; Takano M
    Biochem Biophys Res Commun; 2020 May; 525(3):543-548. PubMed ID: 32113686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate-Induced Epithelial-Mesenchymal Transition in the Alveolar Epithelial Cell Line A549.
    Kawami M; Harabayashi R; Miyamoto M; Harada R; Yumoto R; Takano M
    Lung; 2016 Dec; 194(6):923-930. PubMed ID: 27604426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Nrf2 in Methotrexate-Induced Epithelial-Mesenchymal Transition in Alveolar A549 Cells.
    Kawami M; Honda M; Hara T; Yumoto R; Takano M
    Biol Pharm Bull; 2022; 45(8):1069-1076. PubMed ID: 35908888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of integrin α2 in methotrexate-induced epithelial-mesenchymal transition in alveolar epithelial A549 cells.
    Kawami M; Ojima T; Yumoto R; Takano M
    Toxicol Res; 2022 Oct; 38(4):449-458. PubMed ID: 36277370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation on inhibitory effect of folic acid on methotrexate-induced epithelial-mesenchymal transition focusing on dihydrofolate reductase.
    Kawami M; Honda N; Hara T; Yumoto R; Takano M
    Drug Metab Pharmacokinet; 2019 Dec; 34(6):396-399. PubMed ID: 31601464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cell cycle arrest with anticancer drug-induced epithelial-mesenchymal transition in alveolar epithelial cells.
    Kawami M; Harada R; Ojima T; Yamagami Y; Yumoto R; Takano M
    Toxicology; 2019 Aug; 424():152231. PubMed ID: 31170432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid prevents methotrexate-induced epithelial-mesenchymal transition via suppression of secreted factors from the human alveolar epithelial cell line A549.
    Kawami M; Harabayashi R; Harada R; Yamagami Y; Yumoto R; Takano M
    Biochem Biophys Res Commun; 2018 Feb; 497(1):457-463. PubMed ID: 29448106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.
    Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N
    PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of miR-34a in TGF-β1- and Drug-Induced Epithelial-Mesenchymal Transition in Alveolar Type II Epithelial Cells.
    Takano M; Nekomoto C; Kawami M; Yumoto R
    J Pharm Sci; 2017 Sep; 106(9):2868-2872. PubMed ID: 28408209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of transforming growth factor-β1 on functional expression of monocarboxylate transporter 1 in alveolar epithelial A549 cells.
    Uddin M; Kawami M; Yumoto R; Takano M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 May; 393(5):889-896. PubMed ID: 31900520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
    Sugioka K; Kodama A; Okada K; Iwata M; Yoshida K; Kusaka S; Matsumoto C; Kaji H; Shimomura Y
    Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of uPAR is required for cigarette smoke extract-induced epithelial-mesenchymal transition in lung epithelial cells.
    Wang Q; Wang H; Zhang Y; Zhang Y; Xiao W
    Oncol Res; 2013; 21(6):295-305. PubMed ID: 25198659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.
    Jin G; Su Y; Dong Q; Zhao X; Zhang L; Yan X
    Biochem Biophys Res Commun; 2019 Dec; 520(2):413-419. PubMed ID: 31607474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells.
    Zhang C; Zhu X; Hua Y; Zhao Q; Wang K; Zhen L; Wang G; Lü J; Luo A; Cho WC; Lin X; Yu Z
    Respir Res; 2019 Nov; 20(1):249. PubMed ID: 31703732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Drug-Induced Epithelial-Mesenchymal Transition via p53/miR-34a axis in A549/ABCA3 Cells.
    Yamamoto A; Kawami M; Konaka T; Takenaka S; Yumoto R; Takano M
    J Pharm Pharm Sci; 2019; 22(1):516-524. PubMed ID: 31603744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential mechanisms underlying methotrexate-induced cell death and epithelial-mesenchymal transition in A549 cells.
    Ojima T; Kawami M; Yumoto R; Takano M
    Toxicol Res; 2021 Jul; 37(3):293-300. PubMed ID: 34295794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of TGF-β1- and drug-induced epithelial-mesenchymal transition in cultured alveolar epithelial cell line RLE/Abca3.
    Takano M; Yamamoto C; Yamaguchi K; Kawami M; Yumoto R
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):111-8. PubMed ID: 25760538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury.
    Marudamuthu AS; Bhandary YP; Shetty SK; Fu J; Sathish V; Prakash Y; Shetty S
    Am J Pathol; 2015 Jan; 185(1):55-68. PubMed ID: 25447049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of epithelial-mesenchymal transition in methotrexate-induced pulmonary fibrosis.
    Ohbayashi M; Kubota S; Kawase A; Kohyama N; Kobayashi Y; Yamamoto T
    J Toxicol Sci; 2014 Apr; 39(2):319-30. PubMed ID: 24646714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway.
    Ihara H; Mitsuishi Y; Kato M; Takahashi F; Tajima K; Hayashi T; Hidayat M; Winardi W; Wirawan A; Hayakawa D; Kanamori K; Matsumoto N; Yae T; Sato T; Sasaki S; Takamochi K; Suehara Y; Ogura D; Niwa SI; Suzuki K; Takahashi K
    Respir Investig; 2020 Jul; 58(4):275-284. PubMed ID: 32359980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.